The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

DMNM     2,6-dimethyl-4-nitroso- morpholine

Synonyms: CCRIS 263, CHEMBL164456, AG-D-89628, NSC-69924, LS-7143, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Dimethylnitrosomorpholine

 

High impact information on Dimethylnitrosomorpholine

 

Chemical compound and disease context of Dimethylnitrosomorpholine

 

Biological context of Dimethylnitrosomorpholine

 

Anatomical context of Dimethylnitrosomorpholine

 

Associations of Dimethylnitrosomorpholine with other chemical compounds

 

Gene context of Dimethylnitrosomorpholine

  • BHP, MHP, HPOP and NDMM all caused lung carcinomas to develop (22% to 44% incidence), whereas BOP was only associated with adenomas [15].
 

Analytical, diagnostic and therapeutic context of Dimethylnitrosomorpholine

References

  1. Induction of pancreatic duct of carcinomas in the Syrian hamster with 2,6-dimethylnitrosomorpholine. Mohr, U., Reznik, G., Emminger, E., Lijinsky, W. J. Natl. Cancer Inst. (1977) [Pubmed]
  2. N-nitroso-2,6-dimethylmorpholine-induced hemangiosarcomas in the livers of randombred guinea pigs. Rao, M.S., Scarpelli, D.G., Lijinsky, W. J. Natl. Cancer Inst. (1980) [Pubmed]
  3. Influence of esophagojejunostomy on the induction of adenocarcinoma of the distal esophagus in Sprague-Dawley rats by subcutaneous injection of 2,6-dimethylnitrosomorpholine. Pera, M., Cardesa, A., Bombi, J.A., Ernst, H., Pera, C., Mohr, U. Cancer Res. (1989) [Pubmed]
  4. Comparison of the carcinogenic effects of five nitrosamines in guinea pigs. Cardy, R.H., Lijinsky, W. Cancer Res. (1980) [Pubmed]
  5. Chemically induced tumors of rat olfactory epithelium: a model for human esthesioneuroepithelioma. Vollrath, M., Altmannsberger, M., Weber, K., Osborn, M. J. Natl. Cancer Inst. (1986) [Pubmed]
  6. Comparison of the carcinogenic effectiveness of N-nitrosobis(2-hydroxypropyl)amine, N-nitrosobis(2-oxopropyl)amine, N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine, and N-nitroso-2,6-dimethylmorpholine in Syrian hamsters. Lijinsky, W., Saavedra, J.E., Knutsen, G.L., Kovatch, R.M. J. Natl. Cancer Inst. (1984) [Pubmed]
  7. Carcinogenic effect of N-nitroso-2,6-dimethylmorpholine in Syrian golden hamsters. Reznik, G., Mohr, U., Lijinsky, W. J. Natl. Cancer Inst. (1978) [Pubmed]
  8. Metabolism of pancreatic carcinogens N-nitroso-2,6-dimethylmorpholine and N-nitrosobis(2-oxopropyl)amine by microsomes and cytosol of hamster pancreas and liver. Kokkinakis, D.M., Scarpelli, D.G., Rao, M.S., Hollenberg, P.F. Cancer Res. (1983) [Pubmed]
  9. Expression of cyclin D1 and p53 and its correlation with proliferative activity in the spectrum of esophageal carcinomas induced after duodenal content reflux and 2,6-dimethylnitrosomorpholine administration in rats. Pera, M., Fernandez, P.L., Pera, M., Palacín, A., Cardesa, A., Dasenbrock, C., Tillman, T., Mohr, U. Carcinogenesis (2001) [Pubmed]
  10. Carcinogenic effect of N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine, a postulated proximate pancreatic carcinogen in Syrian hamsters. Pour, P., Wallcave, L., Gingell, R., Nagel, D., Lawson, T., Salmasi, S., Tines, S. Cancer Res. (1979) [Pubmed]
  11. The metabolism and cellular interactions of some aliphatic nitrogenous carcinogens. Lijinsky, W. Cancer Lett. (1985) [Pubmed]
  12. Metabolism of the pancreatic carcinogen N-nitroso-2,6-dimethylmorpholine by hamster liver and component cells of pancreas. Scarpelli, D.G., Kokkinakis, D.M., Rao, M.S., Subbarao, V., Luetteke, N., Hollenberg, P.F. Cancer Res. (1982) [Pubmed]
  13. Metabolism of the cis and trans isomers of N-nitroso-2,6-dimethylmorpholine and their deuterated analogs by liver microsomes of rat and hamster. Kokkinakis, D., Hollenberg, P.F., Scarpelli, D.G. Carcinogenesis (1984) [Pubmed]
  14. Activation of carcinogenic N-nitrosopropylamines to mutagens by lung and pancreas S9 fractions from various animal species and man. Mori, Y., Yamazaki, H., Toyoshi, K., Maruyama, H., Konishi, Y. Mutat. Res. (1986) [Pubmed]
  15. Carcinogenic potency of N-nitrosomethyl(2-hydroxypropyl)amine and other metabolic relatives of N-nitrosobis(2-hydroxypropyl)amine by single intraperitoneal injection on the lung of rats. Yokose, Y., Yamamoto, K., Nakajima, A., Eimoto, H., Maruyama, H., Mori, Y., Konishi, Y. Jpn. J. Cancer Res. (1988) [Pubmed]
  16. Electron microscopic autoradiography of the pancreas in the hamster treated with tritiated N-nitroso-2,6-dimethylmorpholine. Reznik-Schüller, H.M., Lijinsky, W., Hague, B.F. Cancer Res. (1980) [Pubmed]
  17. Spectrum of glandular differentiation in experimental carcinoma of the esophagus induced by 2,6-dimethylnitrosomorpholine under the influence of esophagojejunostomy. Cardesa, A., Bombi, J.A., Pera, M., Fernandez, P.L., Campo, E., Pera, C., Mohr, U. Experimental and toxicologic pathology : official journal of the Gesellschaft für Toxikologische Pathologie. (1994) [Pubmed]
 
WikiGenes - Universities